Field-Flow Fractionation Multi-Angle LIght Scattering (FFF-MALS) System
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The U.S. Food and Drug Administration (FDA), National Forensic Chemistry Center (NFCC), is soliciting quotes for one Field-Flow Fractionation Multi-Angle Light Scattering (FFF-MALS) System with Size Exclusion Chromatography (SEC) capabilities. This Firm Fixed-Price opportunity aims to enhance the NFCC's analytical capabilities for characterizing molecules. Quotes are due July 3, 2026, at 10:00 A.M. ET.
Purpose & Scope
The FDA's NFCC requires an FFF-MALS system to characterize molecules, aiding in determining sample stability and authenticity. This acquisition will expand the center's capabilities for analyzing proteins, peptides, antibodies, vaccines, and polymers. The system will enable the NFCC to perform analyses currently used in the pharmaceutical industry and prepare for future analysis of large molecule therapeutics and biologics.
Key Requirements
The requirement is for one new FFF-MALS system with SEC/MALS/RI/UV detection capabilities. Key specifications include detailed minimum performance requirements for the FFF system, UV Detector, RI Detector, MALS detector, liquid chromatography system, fraction collector, computer system, and software. The system must come with a minimum one-year warranty and include 3-day onsite installation and familiarization, plus 4-day onsite training for up to three personnel.
Contract Details
- Contract Type: Firm Fixed-Price.
- Period of Performance: Begins upon formal government acceptance and continues through the manufacturer’s warranty period.
- Delivery: Equipment required no later than 90 days after contract award.
- Place of Delivery/Performance: U.S. Food and Drug Administration, National Forensic Chemistry Center, 6751 Steger Dr., Cincinnati, OH 45237.
Submission & Evaluation
- Solicitation Number: FDA-OC-2026-132553.
- Quote Submission Deadline: Friday, July 3, 2026, at 10:00 A.M. ET.
- Questions Deadline: Wednesday, June 24, 2026, at 10 a.m. ET.
- Submission Method: Electronically via email to Andrea Howard (andrea.howard1@fda.hhs.gov) and Sephora Calderon (sephora.calderon@fda.hhs.gov). Zip files are not accepted.
- Evaluation Criteria: Award will be made on a Lowest Price Technically Acceptable (LPTA) basis, with the ability to fulfill minimum requirements being significantly more important than price.
Eligibility
- Set-Aside: Full and Open Competition.
- NAICS Code: 334516 (Small Business Size Standard: 1,000 employees).
Contact Information
Primary Contact: Andrea Howard (andrea.howard1@fda.hhs.gov, 240-402-7197).